Powder Delivery TRIZ Cases

Reversible electrostatic cross-linking enables pH-dependent phase transitions, resolving versatility limits in biomedical applications.

Polyelectrolyte complexes stabilize polypeptides and increase brain uptake by bypassing the blood-brain barrier through electrostatic interactions.

Mixing biopolymers with microparticulate ice achieves homogeneous wetting through controlled mechanical energy input.

Antigen-MHC nanoparticle complexes expand anti-inflammatory T-cells, reducing demyelination and spinal cord infiltration without impairing systemic immunity.

Ala-Lys-Pro-Ser-Tyr-Hyp-Hyp-Thr-Tyr-Lys peptide resolves the contradiction between effective anti-inflammatory action and impaired wound healing.

Nano-crystallized herbal packages with anti-caking spacers solve slow extraction times by enabling rapid dissolution while preserving herb-herb interactions.

Low salt PVA resin melt-kneaded with drugs improves bioavailability while eliminating coloration issues common in standard bases.

High molar fraction of proline-carrying peptides in casein hydrolysate reduces side effects while maintaining long-term effectiveness against herpesvirus.

Segmenting therapeutic agents into self-assembling nanocages resolves systemic toxicity by delivering immunogenic cell death inducers directly to tumor sites.

Amino acids stabilize alpha-1 proteinase inhibitor formulations, preventing aggregation and maintaining plasma bioavailability.

Segmented nanoparticles accumulate in tumors via the EPR effect and release smaller carriers to penetrate deep tissue, resolving diffusion limitations.

Sugars and polyols in aqueous viral solutions form an amorphous solid matrix during freeze-drying, preventing protein denaturation without refrigeration.

Silane-functionalized zwitterionic shells bind to silica-free nanoparticle cores to extend blood circulation time while enabling efficient renal clearance.

Anaerostipes rhamnosivorans bacterial composition increases anti-inflammatory cytokine production and enhances epithelial barrier integrity.

A lactitol and Rhamnus frangula extract composition increases intestinal motility through synergistic osmotic and anthraquinone actions.

Opened starch biodegradable material resolves the contradiction between mechanical strength and rapid enzymatic degradation in pharmaceutical implants.

Chitosan and glycyrrhetinic acid nanoparticles encapsulate epigallocatechin gallate to protect the compound from degradation.

Vaporized antiviral nanoparticles coat microparticles to enable inhalation delivery, addressing poor hepatic stability of intravenous treatments.

Replacing toxic inorganic components with biocompatible Car-BDP nanoparticles enables low-power lamp activation for effective deep-tissue photodynamic therapy.

Wet granulation transforms eslicarbazepine acetate powder into high bulk density granules using povidone and croscarmellose sodium.

Polyacrylic acid nanoparticles post-load photosensitizers and fluorophores to enable simultaneous tumor imaging and photodynamic therapy.

Tailored phospholipid ratios replace damaged lipids to resolve mitochondrial dysfunction and improve metabolic rates.

Wild-type S100A3 protein replaces defective variants to restore calcium homeostasis and halt idiopathic pulmonary fibrosis progression.

Topical mepivacaine penetrates skin layers to deliver sustained analgesia, reducing systemic toxicity via intrinsic vasoconstrictor effects.

An enteric coating shields withanolide glycosides from acidic stomach hydrolysis, preserving bioactivity and reducing toxicity.

Optimizing peptide length to 4-9 amino acids resolves the trade-off between neuroprotective reliability and synthesis complexity.

Disulfide-crosslinked silica nanoparticles with PEG surfaces overcome low payload efficiency and cytotoxicity to deliver biomolecules.

Segmenting lactoferrin from simethicone prevents degradation, maintaining bioactivity in a ready-to-mix suspension.

Polymer-coated metal oxide nanoparticles attach fluorochromes to enable high-brightness optical and magnetic resonance imaging agents.

A capsaicin-derived BODIPY photosensitizer activates the TRPV1 protein pathway under low-power LED irradiation.

Polymeric nanoparticles deliver therapeutic agents through brain interstitial spaces via convection-enhanced delivery.

A plunger punctures a non-breakable membrane in a dual-chamber pack, preventing fragment contamination while ensuring stable drug reconstitution.

Segmented nanoparticles overcome microscale clearance barriers, enabling robust antigen-specific T cell proliferation.

Adding N-methyl pyrrolidone reduces formulation viscosity by up to 80%, enabling small-volume subcutaneous injections without aggregation.

A lyophilized formulation stabilizes a GM-CSF neutralizing compound using sucrose and histidine excipients.

A respiratory delivery device uses a cam follower to pierce composition capsules upon cap removal for consistent medicament release.

Guanidinylated polymyxin B derivatives form conjugates with biomolecules to facilitate intracellular uptake via cell surface heparan sulfate.

Administering TLR7/8 agonists restores neutrophil ROS production by upregulating Gp91phox mRNA, overcoming NADPH oxidase deficiency in cirrhotic patients.

Stable PVM/MA nanoparticles overcome gastrointestinal instability to enable effective oral immunotherapy with reduced toxicity.

A dispersion capsule uses sieving mesh and grinding balls to mix cohesive micronized active ingredients with carrier particles.

Freeze-drying converts unstable chlorogenic acid into a solid powder, bypassing intestinal bacteria to ensure high biological availability and clinical safety.

Oral cannabidiol formulations combine edible oils with carriers to overcome low bioavailability and reduce blood pressure.

TIPS produces microspheres with radial pores, resolving irregular pore structures and mechanical weakness in tissue scaffolds.

Continuous peptidic chains self-organize into stable aggregates that resolve mechanical instability and low loading capacity in current carriers.

A peptide targeting ligand conjugated to a charged polymer polypeptide domain directs nucleic acid payloads into cells via endocytosis.

Lactic acid bacteria-derived extracellular vesicles competitively block pathogenic bacterial signals to treat atopic dermatitis without steroid side effects.